Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
Alexandra Tauzin, Gabrielle Gendron‐Lepage, Manon Nayrac, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 532-532
Open Access | Times Cited: 19

Showing 19 citing articles:

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111998-111998
Open Access | Times Cited: 22
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111554-111554
Open Access | Times Cited: 22
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
Laura García, Tom Woudenberg, Jason Rosado, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1491-1491
Open Access | Times Cited: 20
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
Alexandre Nicolas, Gérémy Sannier, Mathieu Dubé, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105904-105904
Open Access | Times Cited: 17
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
Alexandra Tauzin, Guillaume Beaudoin-Bussières, Shang Yu Gong, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104990-104990
Open Access | Times Cited: 11
Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
Lorie Marchitto, Debashree Chatterjee, Shilei Ding, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2004-2004
Open Access | Times Cited: 5
Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
Alexandra Tauzin, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1926-1926
Open Access | Times Cited: 4
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Mark M. Painter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders
Kai M. T. Sauerwein, Christoph B. Geier, R Stemberger, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 922-925
Open Access | Times Cited: 6
Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity
Etsuhisa Takahashi, Takako Sawabuchi, Tetsuya Homma, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1662-1662
Open Access | Times Cited: 3
Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques
Alexandre Laliberté, Caterina Prelli Bozzo, Christiane Stahl‐Hennig, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108351-108351
Open Access | Times Cited: 2
COVID‐19 vaccine humoral response in frequent platelet donors with plateletpheresis‐associated lymphopenia
Annemarie Laumaea, Antoine Lewin, Debashree Chatterjee, et al.
Transfusion (2022) Vol. 62, Iss. 9, pp. 1779-1790
Open Access | Times Cited: 4
SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine
Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine
Ekaterina A. Astakhova, Konstantin O. Baranov, Nadezhda Shilova, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1362-1362
Open Access
High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2
Giulia Maltoni, Lorenzo Scutteri, Francesca Mensitieri, et al.
Biotechnology Letters (2022) Vol. 44, Iss. 11, pp. 1313-1322
Open Access | Times Cited: 3
Real-world data on the Immunity Response to the COVID-19 Vaccine among Patients with Central Nervous System Immunological Diseases
Punchika Kosiyakul, Jiraporn Jitprapaikulsan, Ekdanai Uawithya, et al.
Deleted Journal (2024) Vol. 76, Iss. 2, pp. 69-79
Open Access
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination
Teresa Harthaller, Barbara Falkensammer, David Bante, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
Alexandra Tauzin, Guillaume Beaudoin-Bussières, Shang Yu Gong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity
Annika Rössler, Janine Kimpel, Verena Fleischer, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1909-1912
Open Access | Times Cited: 2
Page 1

Scroll to top